Medtronic PLC
NYSE:MDT
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
79.3038
105.35
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
MDT
stock under the Base Case scenario is
109.5
USD.
Compared to the current market price of 101.99 USD,
Medtronic PLC
is
Undervalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Medtronic PLC.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Medtronic PLC
Balance Sheet Decomposition
Medtronic PLC
| Current Assets | 24B |
| Cash & Short-Term Investments | 8.3B |
| Receivables | 6.4B |
| Other Current Assets | 9.3B |
| Non-Current Assets | 67.4B |
| Long-Term Investments | 851m |
| PP&E | 7.2B |
| Intangibles | 52.6B |
| Other Non-Current Assets | 6.8B |
| Current Liabilities | 9.9B |
| Accounts Payable | 2.6B |
| Accrued Liabilities | 4.9B |
| Other Current Liabilities | 2.4B |
| Non-Current Liabilities | 32.8B |
| Long-Term Debt | 27.7B |
| Other Non-Current Liabilities | 5.1B |
Free Cash Flow Analysis
Medtronic PLC
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Medtronic PLC
|
Revenue
|
34.8B
USD
|
|
Cost of Revenue
|
-12B
USD
|
|
Gross Profit
|
22.8B
USD
|
|
Operating Expenses
|
-16B
USD
|
|
Operating Income
|
6.8B
USD
|
|
Other Expenses
|
-2B
USD
|
|
Net Income
|
4.8B
USD
|
MDT Profitability Score
Profitability Due Diligence
Medtronic PLC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Medtronic PLC's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
MDT Solvency Score
Solvency Due Diligence
Medtronic PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Medtronic PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MDT Price Targets Summary
Medtronic PLC
According to Wall Street analysts, the average 1-year price target for
MDT
is 103.15 USD
with a low forecast of 81.81 USD and a high forecast of 120.75 USD.
Dividends
Current shareholder yield for
MDT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MDT
stock under the Base Case scenario is
109.5
USD.
Compared to the current market price of 101.99 USD,
Medtronic PLC
is
Undervalued by 7%.